How MDMA boosts pleasure and social connection
MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach
Researchers are testing how MDMA and its active parts increase pleasure and social connection to help people with PTSD or depression who struggle with loss of interest.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mclean Hospital NIH-funded |
| Lab location | 1 site (Belmont, United States) |
| Project ID | NIH-11307600 on NIH RePORTER |
What this research studies
This project uses a reverse-translational approach that begins in animals to model human reward learning. In rats, researchers run touchscreen-based reward learning tasks while recording brain activity to find what parts of MDMA drive pro-pleasure effects. They compare stereoselective components and metabolites and study serotonin-related systems linked to anhedonia. The goal is to separate the drug’s helpful effects from unwanted outcomes like neurotoxicity and abuse potential.
Who could benefit from this research
Good fit: This research is most relevant to adults with PTSD or treatment-resistant depression who experience anhedonia and might be candidates for future MDMA-related therapies.
Not a fit: People without loss of pleasure, children, pregnant people, or those with active substance-use disorders may not directly benefit from these findings.
Why it matters
Potential benefit: If successful, this work could lead to safer MDMA-derived treatments that reduce anhedonia in PTSD and depression with fewer side effects.
How similar studies have performed: Clinical trials have shown promising benefits of MDMA-assisted therapy for PTSD and depression, but this animal-based touchscreen and brain-recording approach to pinpoint mechanisms is novel.
Where this research is happening
Belmont, United States
- Mclean Hospital — Belmont, United States (Active)
Researchers
- Principal investigator: Kangas, Brian D. — Mclean Hospital
- Study coordinator: Kangas, Brian D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.